Hardik Parikh Profile - J.P. Morgan Analyst
11 Followers
Hardik Parikh's Stock Coverage
| SYRESpyre Therapeutics | Nov 12, 2026 | BUY | Reiterated | $116.00 | 1Ratings | ― | ― | |
| PCRXPacira Pharmaceuticals | Oct 12, 2026 | HOLD | Upgraded | $36.50 | 14Ratings | -36.48% | ||
| GPCRStructure Therapeutics, Inc. Sponsored ADR | Aug 17, 2026 | BUY | Reiterated | $100.00 | 7Ratings | -31.83% | ||
| KLRAKailera Therapeutics, Inc. | Aug 12, 2026 | BUY | Reiterated | $30.00 | 2Ratings | -34.80% | ||
| VKTXViking Therapeutics | Aug 11, 2026 | BUY | Reiterated | $65.00 | 8Ratings | -12.31% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Hardik Parikh activity FAQ
What is the performance of Hardik Parikh's recommendations?
The percentage of profitable recommendations made by Hardik Parikh is 20.69%, and the average return per transaction is -28.50%.
What stocks does Hardik Parikh cover?
Hardik Parikh mostly covers Spyre Therapeutics, Pacira Pharmaceuticals, Structure Therapeutics, Inc. Sponsored ADR stocks.
What was Hardik Parikh's most profitable rating?
Hardik Parikh’s most profitable rating was a buy on Structure Therapeutics, Inc. Sponsored ADR stock on Sep 04, 2025. The return on the trade was 139.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here